Big-time progress in cardiovascular genomics

Two important recent studies--pertaining to Sporadic Thoracic Aortic Aneurysms and Dissections (STAAD) and hypertension--point to remarkable progress in the realm of genomic research and pave the way to better understanding of cardiovascular disease and improved treatment options.

How do you think this genomic research will add to our understanding of CV disease?

See also:

• Aortic dissection and Marfan's have common genetic basis
• New gene studies "huge step forward" in understanding hypertension
• Le Maire SA et al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet 2011. Abstract.
• The International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011. Abstract.

Your comments

	Big-time progress in cardiovascular genomics
	# 1 of 1	March 15, 2012 02:27 (EDT)
	Michael Hennessey	Hi Eric. I hope you can help by giving me some direction. I have secondary bowel cancer in my pelvis and one locus in my lung. I have just started a course of chemo - 5FU and radiotherapy. You book describes the concept of tailoring chemo to specific tumors. Could you please suggest a name of someone that I could contact to discuss such therapy? I live in Ireland and am very willing to travel anywhere in the world to receive thsi specific therapy. Hope to hear from you soon. Kind regards, Michael.

You must be a member (with full membership) to post a comment.

Already a member?

Enter your login information below:

 Remember me on this computer

Forgot your username and/or password?

        Login        

Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access